Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Suzuken Co ( (JP:9987) ) has issued an update.
Suzuken Co., Ltd. announced the results of its share repurchase for September 2025, acquiring 358,400 common shares for approximately ¥2.15 billion through market purchases on the Tokyo Stock Exchange. This repurchase is part of a larger plan, announced in May 2025, to buy back up to 5.2 million shares by March 2026, aiming to enhance shareholder value and optimize capital structure.
The most recent analyst rating on (JP:9987) stock is a Hold with a Yen6387.00 price target. To see the full list of analyst forecasts on Suzuken Co stock, see the JP:9987 Stock Forecast page.
More about Suzuken Co
Suzuken Co., Ltd. operates in the healthcare industry, focusing on the distribution of pharmaceuticals and medical devices. It is publicly traded on the Tokyo, Nagoya, and Sapporo Stock Exchanges.
Average Trading Volume: 178,085
Technical Sentiment Signal: Buy
Current Market Cap: Yen331.7B
For a thorough assessment of 9987 stock, go to TipRanks’ Stock Analysis page.